CN111088270A - 一种制备永生化树突状细胞的基因、载体、方法和永生化树突状细胞 - Google Patents
一种制备永生化树突状细胞的基因、载体、方法和永生化树突状细胞 Download PDFInfo
- Publication number
- CN111088270A CN111088270A CN201911397010.2A CN201911397010A CN111088270A CN 111088270 A CN111088270 A CN 111088270A CN 201911397010 A CN201911397010 A CN 201911397010A CN 111088270 A CN111088270 A CN 111088270A
- Authority
- CN
- China
- Prior art keywords
- gene
- cells
- immortalized
- vector
- dendritic cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
PBMC1 | A0207 | A1101 | B3901 | B4601 | C0102 | C0702 |
PBMC2 | A0101 | A2601 | B3501 | B3701 | C0401 | C0602 |
PBMC3 | A0101 | A3303 | B3801 | B5801 | C0302 | C1203 |
PBMC4 | A0201 | A0201 | B0702 | B1501 | C0303 | C0702 |
PBMC5 | A1101 | A3001 | B1302 | B4601 | C0102 | C0602 |
PBMC6 | A2601 | A3303 | B1301 | B5401 | C0102 | C1202 |
PBMC7 | A0301 | A1101 | B3503 | B3901 | C0702 | C1203 |
PBMC8 | A0301 | A2402 | B1501 | B5501 | C0102 | C0702 |
PBMC9 | A0206 | A0207 | B1501 | B4601 | C0102 | C0401 |
PBMC10 | A0206 | A3001 | B4601 | B5101 | C0102 | C1602 |
PBMC11 | A0101 | A2402 | B3701 | B5102 | C0602 | C1502 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911397010.2A CN111088270B (zh) | 2019-12-30 | 2019-12-30 | 一种制备永生化树突状细胞的基因、载体、方法和永生化树突状细胞 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911397010.2A CN111088270B (zh) | 2019-12-30 | 2019-12-30 | 一种制备永生化树突状细胞的基因、载体、方法和永生化树突状细胞 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111088270A true CN111088270A (zh) | 2020-05-01 |
CN111088270B CN111088270B (zh) | 2020-10-09 |
Family
ID=70396976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911397010.2A Active CN111088270B (zh) | 2019-12-30 | 2019-12-30 | 一种制备永生化树突状细胞的基因、载体、方法和永生化树突状细胞 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111088270B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112409496A (zh) * | 2020-11-26 | 2021-02-26 | 焦顺昌 | 一种跨膜表达新型冠状病毒抗原s2的融合蛋白、重组载体、重组树突状细胞及其应用 |
CN112899308A (zh) * | 2021-02-05 | 2021-06-04 | 北京鼎成肽源生物技术有限公司 | 一种电转染永生化树突状细胞的方法 |
US11696949B2 (en) * | 2020-03-09 | 2023-07-11 | Beijing Dcty Biotech Co., Ltd. | Coronavirus-targeting universal DC cell vaccine, and preparation method and use thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104450620A (zh) * | 2014-06-09 | 2015-03-25 | 重庆医科大学附属儿童医院 | 一种携带双自杀基因的可回复永生化肝细胞株及其构建方法 |
CN108289909A (zh) * | 2015-10-19 | 2018-07-17 | 巴尔的摩马里兰大学 | 用于产生工程改造的人原代血液树突细胞系的方法 |
CN109957582A (zh) * | 2017-12-26 | 2019-07-02 | 上海尚泰生物技术有限公司 | 一种靶向肿瘤多种kras突变抗原表位的细胞毒性t淋巴细胞的制备方法 |
CN110195042A (zh) * | 2019-06-11 | 2019-09-03 | 焦顺昌 | 一种树突状细胞的制备方法及应用 |
-
2019
- 2019-12-30 CN CN201911397010.2A patent/CN111088270B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104450620A (zh) * | 2014-06-09 | 2015-03-25 | 重庆医科大学附属儿童医院 | 一种携带双自杀基因的可回复永生化肝细胞株及其构建方法 |
CN108289909A (zh) * | 2015-10-19 | 2018-07-17 | 巴尔的摩马里兰大学 | 用于产生工程改造的人原代血液树突细胞系的方法 |
CN109957582A (zh) * | 2017-12-26 | 2019-07-02 | 上海尚泰生物技术有限公司 | 一种靶向肿瘤多种kras突变抗原表位的细胞毒性t淋巴细胞的制备方法 |
CN110195042A (zh) * | 2019-06-11 | 2019-09-03 | 焦顺昌 | 一种树突状细胞的制备方法及应用 |
Non-Patent Citations (1)
Title |
---|
HATFULL,G.F.等: "NCBI Reference Sequence: YP_001491611.1", 《GENBANK》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11696949B2 (en) * | 2020-03-09 | 2023-07-11 | Beijing Dcty Biotech Co., Ltd. | Coronavirus-targeting universal DC cell vaccine, and preparation method and use thereof |
CN112409496A (zh) * | 2020-11-26 | 2021-02-26 | 焦顺昌 | 一种跨膜表达新型冠状病毒抗原s2的融合蛋白、重组载体、重组树突状细胞及其应用 |
CN112409496B (zh) * | 2020-11-26 | 2021-07-13 | 焦顺昌 | 一种跨膜表达新型冠状病毒抗原s2的融合蛋白、重组载体、重组树突状细胞及其应用 |
CN112899308A (zh) * | 2021-02-05 | 2021-06-04 | 北京鼎成肽源生物技术有限公司 | 一种电转染永生化树突状细胞的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111088270B (zh) | 2020-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111088270B (zh) | 一种制备永生化树突状细胞的基因、载体、方法和永生化树突状细胞 | |
CN111330002B (zh) | 靶向冠状病毒的通用dc细胞疫苗及其制备方法和应用 | |
CN107922925B (zh) | 用于自然杀伤细胞扩增的方法 | |
CN112592928B (zh) | 冠状病毒的融合基因、融合蛋白、重组载体、通用型dc疫苗及其制备方法 | |
CN107075484A (zh) | 从多能性干细胞诱导细胞免疫治疗用t细胞的方法 | |
CN107164332B (zh) | 经干扰序列修饰的TGF-β1缄默的白血病细胞外泌体及其制备方法和应用 | |
US20210371823A1 (en) | Method for expanding human dc cell and human dc cell resource library | |
CN105924533A (zh) | Ror1特异性嵌合抗原受体及其应用 | |
CN112251406A (zh) | 一种nk细胞活化阶段的外泌体分选方法 | |
CN108300693A (zh) | 一种自然杀伤细胞体外扩增方法 | |
CN108060129A (zh) | 调节性t细胞体外扩增方法 | |
CN112626027A (zh) | 一种Treg细胞培养方法 | |
US20210324333A1 (en) | Method for enhancing production of genetically engineered autologous t cells | |
US20230015932A1 (en) | Method of generation of lympho-myeloid niches | |
CN111172110B (zh) | 一种脐带血cik细胞的培养方法 | |
JP2023522642A (ja) | 遺伝子改変自己t細胞を製造するためのプロセス | |
CN109957543A (zh) | 利用脐带血大量扩增脐血nk细胞的方法 | |
CN107794269A (zh) | 促进基因编辑t细胞活化及扩增的生物膜、制法及应用 | |
CN108753729B (zh) | 一种用于检验tcr-t细胞杀伤效果的靶细胞及其制备方法和应用 | |
CN112725273A (zh) | 一种nk细胞及其制备方法和应用 | |
CN110904052A (zh) | 一种snk细胞的培养方法 | |
CN108251370B (zh) | 非细胞来源的多肽致敏的dc-cik细胞、其构建方法及应用 | |
CN109385437B (zh) | Dna分子、含有该dna分子的载体以及获得的永生化细胞 | |
US20200362014A1 (en) | Applications of soluble protein baff in b cell in-vitro culture and proliferation | |
CN113249331B (zh) | 负载Tax抗原的DC细胞、CTL细胞及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Jiao Shunchang Inventor after: Zhang Rong Inventor after: Chen Yin Inventor after: Chen Xiaobin Inventor after: Chen Hongli Inventor before: Jiao Shunchang Inventor before: Zhang Rong Inventor before: Chen Yin |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Jiao Shunchang Inventor after: Zhang Rong Inventor after: Chen Xiaobin Inventor after: Chen Hongli Inventor after: Chen Yin Inventor before: Jiao Shunchang Inventor before: Zhang Rong Inventor before: Chen Yin Inventor before: Chen Xiaobin Inventor before: Chen Hongli |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |